Otsuka Pharmaceutical Co., Ltd.
215
16
20
174
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
7.4%
16 terminated/withdrawn out of 215 trials
91.6%
+5.1% vs industry average
43%
92 trials in Phase 3/4
83%
144 of 174 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (215)
Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
Role: collaborator
Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
Role: collaborator
A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL
Role: lead
Kaempferol Absorption and Pharmacokinetics Evaluation
Role: collaborator
A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma
Role: lead
A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
Role: lead
Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
Role: lead
A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
Role: lead
A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
Role: lead
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
Role: lead
Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
Role: lead
Software as a Medical Device for the Treatment of Patients With PTSD
Role: collaborator
A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])
Role: lead
A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis
Role: lead
LUPKYNIS Drug-use Results Survey
Role: lead
A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis
Role: lead
A Pilot Study to Evaluate Equol and Its Effects on Menopausal Symptoms Experienced by Women in Singapore
Role: collaborator
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Role: lead
A Long-term Trial of EB-1020 in Adult Patients With ADHD
Role: lead
Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders
Role: collaborator